SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells.

Saved in:
Bibliographic Details
Title: SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells.
Authors: Zhang L; Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston, TX.; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX., Hsu JI; Translational Biology and Molecular Medicine Graduate Program, Baylor College of Medicine, Houston, TX.; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX., Braekeleer ED; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge., Chen CW; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX.; Integrated Molecular and Biomedical Sciences Graduate Program, Baylor College of Medicine, Houston, TX., Patel TD; Texas Children's Hospital Department of Hematology/Oncology, Baylor College of Medicine, Houston, TX., Martell AG; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX., Guzman AG; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX., Wohlan K; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX., Waldvogel SM; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX.; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX.; Cancer and Cell Biology Graduate Program, Baylor College of Medicine, Houston, TX., Urya H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Tovy A; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX., Callen E; Laboratory of Genome Integrity, National Cancer Institute, National Institute of Health, Bethesda, MD., Murdaugh R; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX.; Department of Neurosurgery, Baylor College of Medicine, Houston, TX., Richard R; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX.; Department of Neurosurgery, Baylor College of Medicine, Houston, TX., Jansen S; Donders Centre for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands., Vissers L; Donders Centre for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands., de Vries BBA; Donders Centre for Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands., Nussenzweig A; Cancer and Cell Biology Graduate Program, Baylor College of Medicine, Houston, TX., Huang S; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Department of Education, Innovation and Technology, Advanced Technology Cores., Coarfa C; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX., Anastas JN; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX.; Department of Neurosurgery, Baylor College of Medicine, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Education, Innovation and Technology, Advanced Technology Cores., Vassiliou G; Department of Haematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge., Goodell MA; Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston TX.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.; Center for Cell and Gene Therapy, Houston, TX.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jan 17. Date of Electronic Publication: 2024 Jan 17.
Publication Type: Preprint; Journal Article
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2023.08.31.555634